← Leaderboards
Cristina Maria Fernandez-Valle
University Of Central Florida
$5,257,998
Attributed
$6,806,214
Total exposure
6
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.1M · FY2009–22$2M$1.5M$1M$500K$0
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
Funding mix
By agency
NIH$6,806,214 · 6
By mechanism
R01$5,844,053 · 4
S10$500,000 · 1
R56$462,161 · 1
Top collaborators
- Xue Z Liu5 shared
Others in their field
Top investigators on “Tumor Suppressor Proteins”
- Scott W Lowe · Sloan-Kettering Inst Can Research$30,621,807
- Carol Prives · Icahn School Of Medicine At Mount Sinai$25,974,663
- Pier Paolo Pandolfi · Sloan-Kettering Institute For Cancer Res$25,707,040
- Xinbin Chen · Medical College Of Georgia (Mcg)$23,449,975
- Carlo M Croce · Thomas Jefferson University$21,878,300
- Wei Gu · Columbia University Health Sciences$21,628,257
Research focus
Tumor Suppressor ProteinsSchwann CellsCellsLifeNeurofibromatosis 2GenesTumorNeurofibromin 2Signal PathwayIn VitroPreventPathway InteractionsMolecularNervePhenotypeReportingResponseRattusMutationNeurilemmomaBrain StemHearingFacial ParalysisGrowth
Grant awards (17)
Preclinical Testing of PI3K Inhibitors for Vestibular Schwannomas$556,980
R01 · FY2022 · DC · contact PI
Preclinical Testing of PI3K Inhibitors for Vestibular Schwannomas$638,661
R01 · FY2021 · DC · contact PI
Preclinical Testing of PI3K Inhibitors for Vestibular Schwannomas$640,803
R01 · FY2020 · DC · contact PI
Preclinical Testing of PI3K Inhibitors for Vestibular Schwannomas$622,304
R01 · FY2019 · DC · contact PI
Preclinical Testing of PI3K Inhibitors for Vestibular Schwannomas$637,684
R01 · FY2018 · DC · contact PI
Co-targeting FAK and PI3K for NF2 Schwannomas$462,161
R56 · FY2018 · NS · contact PI
Identification of Novel Drug Targets For Use in Preventing Deafness Caused by NF2$273,738
R01 · FY2013 · DC · contact PI
Identification of Novel Drug Targets For Use in Preventing Deafness Caused by NF2$288,147
R01 · FY2012 · DC · contact PI
Identification of Novel Drug Targets For Use in Preventing Deafness Caused by NF2$287,121
R01 · FY2011 · DC · contact PI
ZEISS Spinning Disc/LSM700 Point Scanning Confocal Microscope with Incubation Sys$500,000
S10 · FY2010 · RR · contact PI
Mechanisms Modulating Cytoskeletal Dynamics During Schwann Cell Myelination$318,593
R01 · FY2010 · NS · contact PI
Identification of Novel Drug Targets For Use in Preventing Deafness Caused by NF2$296,612
R01 · FY2010 · DC · contact PI
Mechanisms Modulating Cytoskeletal Dynamics During Schwann Cell Myelination$403,582
R01 · FY2009 · NS · contact PI
Identification of Novel Drug Targets For Use in Preventing Deafness Caused by NF2$296,038
R01 · FY2009 · DC · contact PI
CONTROL OF SCHWANN CELL DIFFERENTIATION$200,376
R01 · FY2002 · NS
CONTROL OF SCHWANN CELL DIFFERENTIATION$194,540
R01 · FY2001 · NS
CONTROL OF SCHWANN CELL DIFFERENTIATION$188,874
R01 · FY2000 · NS